ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Director, Global Value & Access Strategy (GVAS), Cell-therapy Autoimmune at Gilead Sciences - ApplyBlast

Director, Global Value & Access Strategy (GVAS), Cell-therapy Autoimmune

Gilead Sciences

28 days ago

3.5 on Glassdoor

El Segundo, California, United States

Hybrid

Full Time

Director

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

This role serves as a critical Global Value & Access partner for Kite's autoimmune cell therapy portfolio, leading the development and execution of global market access strategies from early development through launch. The position involves collaborating with cross-functional teams to incorporate payer perspectives into development decisions, shaping evidence generation strategies, and ensuring favorable reimbursement and patient access outcomes across major global markets. The Director will provide strategic leadership on market access dynamics, value demonstration, and cross-functional alignment to support the lifecycle management of transformative cell therapies.

Responsibilities

Lead development and execution of global market access strategies for autoimmune cell therapy portfolio
Partner with cross-functional teams to integrate payer perspectives into clinical development and evidence generation
Advise on economic models, burden-of-illness studies, and value demonstration for reimbursement and pricing

Skills

Qualifications

PhDPharmDMSMAMBA

About Gilead Sciences

gilead.com

Headquarters

Foster City, California, United States

Company Size

10001+ employees

Founded

1987

View Profile

Gilead Sciences is a biopharmaceutical company dedicated to transforming patient care by advancing therapeutics in areas like HIV, liver disease, cancer, and inflammation. With a strong commitment to innovation, Gilead leads in the research and development of new medicines, aiming to make the world a healthier place. Their portfolio includes breakthrough therapies and ongoing advancements across multiple therapeutic areas, supported by a robust pipeline of clinical trials. Gilead is recognized for its contributions to public health and its efforts to improve access to vital medications.